Skin Booster vs Aqua-Shine Injection: What's the Difference?
A Seoul dermatologist explains, with clinical studies, how HA aqua-shine injections and PN/PLLA skin boosters differ — mechanism, duration, and who each one suits.
This is an English adaptation of a clinical article Dr. SangYoul Yun — board-certified dermatologist and Medical Director of Delight Dermatology in Gangnam, Seoul — originally published in Korean. Read the Korean original on Naver. It has been restructured and translated for international readers; all references are the author's own.
Running a dermatology clinic in Gangnam, there is one question I hear every single week: "Doctor, is a skin booster right for me, or an aqua-shine injection?" Both are injected directly into the skin, so they look similar — but their ingredients, mechanism of action, duration, and indications are clearly different. Most of what circulates online is written from a marketing angle and isn't accurate, so here I'll lay out the difference based on actual clinical studies.
1. Definitions first — the two are actually a "subset" relationship
Many people think "skin booster ≠ aqua-shine injection," but strictly speaking an aqua-shine injection is one type of skin booster.
- Aqua-shine injection (HA skin booster) — non-crosslinked or lightly crosslinked hyaluronic acid (HA) injected into the dermis. Representative products include Restylane Vital, Juvederm Skinvive, and IBSA Profhilo; the goal is immediate hydration and skin glow.
- Skin booster (the broader category) — includes not only HA but a range of regenerative ingredients: polynucleotide (PN/PDRN), PLLA, PCL, exosomes, and more. Representative products include Rejuran (PN), Juvelook (PLLA+HA), Ellansé and Juvelook Volume (PCL), and exosomes; the goal is skin regeneration and collagen neogenesis.
In other words, "aqua-shine vs skin booster" is more precisely understood as "HA skin booster vs PN/PLLA-family skin booster."
2. Mechanism of action — the fundamental difference in the literature
Hyaluronic acid is a hydrophilic molecule that can bind up to 1,000 times its own weight in water. Injected into the dermis, it immediately draws in water to create volume and radiance. However, non-crosslinked HA is broken down by hyaluronidase in the body, so its clinical effect is reported to last, on average, 1–3 months.1
Polynucleotide (PN) and polydeoxyribonucleotide (PDRN) are low-molecular-weight DNA fragments extracted from the sperm DNA of salmonid fish (Oncorhynchus mykiss). Rather than simply filling space, PN/PDRN activate the adenosine A2A receptor on the surface of fibroblasts, inducing the following changes:2
- Increased type I collagen synthesis
- Increased VEGF (vascular endothelial growth factor) expression → improved microcirculation
- Anti-inflammatory effect (reduced inflammatory cytokines)
- Promotion of cell proliferation and tissue regeneration
So if HA is a procedure that "fills the skin with water," the PN family is one that "signals the skin to regenerate itself."
3. Clinical effect — what the studies actually show
HA skin booster
In a clinical study of Profhilo delivered with the 5-point BAP technique, two sessions four weeks apart improved skin elasticity, hydration, and texture, with the effect reported to last around 6 months on average.3
PN family
Park et al. (2016, Dermatologic Therapy) treated five Korean women in their 30s–40s with PN over four sessions at two-week intervals: patients in their 30s showed marked improvement in pore size and skin thickness, while patients in their 40s improved in skin tone, melanin, fine wrinkles, and sagging — with no serious adverse events.4
Lee et al. (2022, Journal of Dermatological Treatment) is even more decisive — a randomized, double-blind, split-face trial. PN and HA filler were injected into the left and right periocular areas of the same patients, and the PN side was significantly superior to the HA side in skin elasticity and texture improvement.5
PN for facial erythema
A clinical study published on PMC reported that after three PN sessions, erythema of the forehead, cheeks, and chin objectively improved.6 This supports PN's anti-inflammatory action and microvascular stabilization. In practice, Rejuran can also be used to improve facial redness.
4. Which patient suits which procedure?
Here is the exact framework I share with patients in clinic.
| Concern | Recommended | Why |
|---|---|---|
| Dehydration, dullness, need for immediate glow | Aqua-shine injection (HA) | Immediate hydration, good value |
| Pores, fine wrinkles, early loss of elasticity (30s+) | PN family (Rejuran, etc.) | Collagen neogenesis, regeneration |
| Aging changes in earnest (late 30s+) | PLLA family (Juvelook, etc.) | Long-term collagen remodeling |
| Facial redness / sensitive skin | PN family | Anti-inflammatory + regeneration together |
| Need for rapid, combined regeneration | Exosome + PN combined | Synergistic effect |
5. Side effects and aftercare
Both procedures have an excellent safety profile, but there are points worth knowing.
- Common (temporary) — bruising, swelling, and redness at the injection site, resolving within 3–7 days.
- PN-specific — a transient nodular feeling right after treatment, which resolves with gentle massage after 24 hours. Patients with a salmon allergy must disclose it beforehand.
- PLLA-specific — rarely, delayed nodules (possible months after treatment); massage 5 times a day for 5 days is recommended (the "5-5-5 rule").
6. How we approach this at Delight Dermatology
At our clinic, "we don't fit the patient to an ingredient — we fit the ingredient to the patient." The first question isn't "is aqua-shine or skin booster better?" but "what is my skin condition and goal?" If you simply need hydration, an aqua-shine skin booster is enough. But if you're seeing aging changes from your mid-30s — loss of elasticity, enlarged pores, fine wrinkles — a PN or PLLA-family skin booster is the better fit. I recommend deciding only after you understand the ingredient and mechanism and have your skin objectively assessed.
References
- Cavallini M, Bartoletti E, Maioli L, et al. Consensus report on the use of PN-HPT™ (polynucleotides highly purified technology) in aesthetic medicine. J Cosmet Dermatol. 2021;20(3):922-928.
- Squadrito F, Bitto A, Irrera N, et al. Pharmacological activity and clinical use of PDRN. Front Pharmacol. 2017;8:224.
- Kim YJ, et al. Polydeoxyribonucleotide promotes wound healing via the adenosine A2A receptor. Ann Dermatol. 2016;28(5):616-623.
- Park KY, Seok J, Rho NK, Kim BJ, Kim MN. Long-chain polynucleotide filler for skin rejuvenation: efficacy and complications in five patients. Dermatol Ther. 2016;29(1):37-40.
- Lee YJ, Kim HT, Lee YJ, et al. Comparison of the effects of polynucleotide and hyaluronic acid fillers on periocular rejuvenation: a randomized, double-blind, split-face trial. J Dermatolog Treat. 2022;33(1):254-260.
- Lee D, Kim MJ, Park HJ, et al. Clinical effects of polynucleotide with hyaluronic acid intradermal injections on facial erythema. Skin Res Technol. 2023;29(9):e13466.
Medical disclaimer. This article is general information and does not replace individual consultation. Whether a skin booster or aqua-shine injection suits you, and the possibility of side effects, should be decided through an in-person consultation with a dermatologist. If you have a salmon or fish allergy, please tell us before treatment.
Lưu ý: Thông tin trong bài chỉ mang tính giáo dục chung, không thay thế tư vấn y khoa. Kế hoạch điều trị cá nhân được xác định qua buổi tư vấn với bác sĩ da liễu chuyên khoa. Kết quả có thể khác nhau.
Liệu trình liên quan
